| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.21 | 0.005 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |